Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ISIN: LU2458332611 | Ticker: ALVO | LEI: 222100DCZBOWV5DZ8372

About Alvotech Holdings S.A

Company Description

We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do.

We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives.

It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars.

Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission.

We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.

Year founded

2018

Served area

Worldwide

Headquarters

9 rue de Bitbourg, 1273 Luxembourg – Luxembourg

Filings & Publications

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

289,727,462

IPO

June 23, 2022

Stock exchange(s)

Luxembourg Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.